Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity - PubMed (original) (raw)
. 2005 Mar 11;280(10):9519-27.
doi: 10.1074/jbc.M413808200. Epub 2005 Jan 4.
Affiliations
- PMID: 15632134
- DOI: 10.1074/jbc.M413808200
Free article
Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity
Dae J Kim et al. J Biol Chem. 2005.
Free article
Abstract
Recent work has shown that peroxisome proliferator-activated receptor beta (PPARbeta) attenuates cell proliferation and skin carcinogenesis, and this is due in part to regulation of ubiquitin C expression. In these studies, the role of PPARbeta in modulating ubiquitin-dependent protein kinase Calpha (PKCalpha) levels and phosphorylation signaling pathways was evaluated. Intracellular phosphorylation analysis showed that phosphorylated PKCalpha and other kinases were lower in wild-type mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) as compared with PPARbeta-null mouse skin. No differences in expression levels of other PKC isoforms present in skin were observed. Lower ubiquitination of PKCalpha was found in TPA-treated PPARbeta-null skin as compared with wild-type, and inhibition of ubiquitin-dependent proteasome degradation prevented TPA-induced down-regulation of PKCalpha. The activity of PKCalpha and downstream signaling kinases is enhanced, and expression of cyclooxygenase-2 (COX-2) is significantly greater, in PPARbeta-null mouse skin in response to TPA compared with wild-type mouse skin. Inhibition of PKCalpha or COX-2 reduced cell proliferation in TPA-treated PPARbeta-null keratinocytes in a dose-dependent manner, whereas it only slightly influenced cell proliferation in wild-type keratinocytes. Combined, these studies provide strong evidence that PPARbeta attenuates cell proliferation by modulating PKCalpha/Raf1/MEK/ERK activity that may be due in part to reduced ubiquitin-dependent turnover of PKCalpha.
Similar articles
- Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT, Zhu B, Kang BH, Gonzalez FJ, Peters JM. Bility MT, et al. Toxicol Sci. 2010 Jan;113(1):27-36. doi: 10.1093/toxsci/kfp212. Epub 2009 Sep 11. Toxicol Sci. 2010. PMID: 19748995 Free PMC article. - Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.
Peters JM, Gonzalez FJ. Peters JM, et al. Biochim Biophys Acta. 2009 Dec;1796(2):230-41. doi: 10.1016/j.bbcan.2009.06.002. Epub 2009 Jun 6. Biochim Biophys Acta. 2009. PMID: 19505534 Free PMC article. Review. - Nuclear receptor peroxisome proliferator activated receptor (PPAR) β/δ in skin wound healing and cancer.
Montagner A, Wahli W, Tan NS. Montagner A, et al. Eur J Dermatol. 2015 Apr;25 Suppl 1:4-11. doi: 10.1684/ejd.2014.2505. Eur J Dermatol. 2015. PMID: 26287030 Review.
Cited by
- Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.
Peters JM, Foreman JE, Gonzalez FJ. Peters JM, et al. Cancer Metastasis Rev. 2011 Dec;30(3-4):619-40. doi: 10.1007/s10555-011-9320-1. Cancer Metastasis Rev. 2011. PMID: 22037942 Free PMC article. Review. - PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-κB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathway.
Schnegg CI, Kooshki M, Hsu FC, Sui G, Robbins ME. Schnegg CI, et al. Free Radic Biol Med. 2012 May 1;52(9):1734-43. doi: 10.1016/j.freeradbiomed.2012.02.032. Epub 2012 Mar 3. Free Radic Biol Med. 2012. PMID: 22387176 Free PMC article. - Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?
Weindl G, Schäfer-Korting M, Schaller M, Korting HC. Weindl G, et al. Drugs. 2005;65(14):1919-34. doi: 10.2165/00003495-200565140-00002. Drugs. 2005. PMID: 16162018 Review. - Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis.
Hyter S, Indra AK. Hyter S, et al. FEBS Lett. 2013 Mar 18;587(6):529-41. doi: 10.1016/j.febslet.2013.01.041. Epub 2013 Feb 5. FEBS Lett. 2013. PMID: 23395795 Free PMC article. Review. - Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer X, Laguna JC, Michalik L, Wahli W, Vázquez-Carrera M. Rodríguez-Calvo R, et al. Diabetes. 2008 Aug;57(8):2149-57. doi: 10.2337/db08-0176. Epub 2008 Apr 28. Diabetes. 2008. PMID: 18443198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous